Corrigendum to "Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation" [European Journal of Pharmacology 600 (2008) 117-122] (DOI:10.1016/j.ejphar.2008.09.031);Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation

European Journal of Pharmacology

Volumn 600, Issue 1-3, 2008, Pages 117-122

  Williams, Alison S ^a   Issa, Razao ^a   Durham, Andrew ^a   Leung, Sum Yee ^a   Kapoun, Ann ^b   Medicherla, Satyanarayana ^b   Higgins, Linda S ^b   Adcock, Ian M ^a   Chung, Kian Fan ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b SCIOS INC   (United States)

Author keywords

Airway hyperresponsiveness; Neutrophil; Oxidative stress; Ozone; p38 mitogen activated protein kinase (MAPK); SD 282

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; OZONE; SD 282; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; GENE EXPRESSION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL;

EID: 55949102910     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.029     Document Type: Erratum

References (53)

1. Adler V., Yin Z., Tew K.D., and Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18 (1999) 6104-6111
2. Balmes J.R., Aris R.M., Chen L.L., Scannell C., Tager I.B., Finkbeiner W., Christian D., Kelly T., Hearne P.Q., Ferrando R., and Welch B. Effects of ozone on normal and potentially sensitive human subjects. Part I: airway inflammation and responsiveness to ozone in normal and asthmatic subjects. Res. Rep. Health Effic. Inst. (1997) 1-37
3. Bhalla D.K., and Gupta S.K. Lung injury, inflammation, and inflammatory stimuli in rats exposed to ozone. J. Toxicol. Environ. Health 59 (2000) 211-228
4. Bhalla D.K., Reinhart P.G., Bai C., and Gupta S.K. Amelioration of ozone-induced lung injury by anti-tumor necrosis factor-alpha. Toxicol. Sci. 69 (2002) 400-408
5. Cho H.Y., Zhang L.Y., and Kleeberger S.R. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Am. J. Physiol. Lung Cell Mol. Physiol. 280 (2001) L537-L546
6. D'Acquisto F., Iuvone T., Rombola L., Sautebin L., Di Rosa M., and Carnuccio R. Involvement of NF-kB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett. 418 (1997) 175-178
7. Dean J.L.E., Sully G., Clark A.R., and Saklatvala J. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell. Signal. 16 (2004) 1113-1121
8. Eiswerth M.E., Douglass Shaw W., and Yen S.T. Impacts of ozone on the activities of asthmatics: revisiting the data. J. Environ. Manag. 77 (2005) 56-63
9. English J.M., and Cobb M.H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 23 (2002) 40-45
10. Fabbri L.M., Aizawa H., Alpert S.E., Walters E.H., O'Byrne P.M., Gold B.D., Nadel J.A., and Holtzman M.J. Airway hyperresponsiveness and changes in cell counts in bronchoalveolar lavage after ozone exposure in dogs. Am. Rev. Respir. Dis. 129 (1984) 288-291
11. Galan I., Tobias A., Banegas J.R., and Aranguez E. Short-term effects of air pollution on daily asthma emergency room admissions. Eur. Respir. J. 22 (2003) 802-808
12. Haddad E.B., Salmon M., Koto H., Barnes P.J., Adcock I., and Chung K.F. Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor-kappa b in rat lung: inhibition by corticosteroids. FEBS Lett. 379 (1996) 265-268
13. Han J., Lee J.D., Bibbs L., and Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265 (1994) 808-811
14. Hisada T., Adcock I.M., Nasuhara Y., Salmon M., Huang T.J., Barnes P.J., and Chung K.F. Inhibition of ozone-induced lung neutrophilia and nuclear factor-kappaB binding activity by vitamin A in rat. Eur. J. Pharmacol. 377 (1999) 63-68
15. Inoue H., Aiziwa H., Nakano H., Matsumoto K., Kuwano K., Nadel J.A., and Hara N. Nitric oxide synthase inhibitors attenuate ozone-induced airway inflammation in guinea pigs. possible role of interleukin-8. Am. J. Respir. Crit. Care Med. 161 (2000) 249-256
16. Johnston C.J., Stripp B.R., Reynolds S.D., Avissar N.E., Reed C.K., and Finkelstein J.N. Inflammatory and antioxidant gene expression in C57BL/6 J mice after lethal and sublethal ozone exposures. Exp. Lung Res. 25 (1999) 81-97
17. Johnston R.A., Mizgerd J.P., and Shore S.A. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. A.J.P. - Lung Cell Mol. Physiol. 288 (2005) L61-L67
18. Johnston R.A., Schwartzman I.N., Flynt L., and Shore S.A. Role of interleukin-6 in murine airway responses to ozone. A.J.P. - Lung Cell Mol. Physiol. 288 (2005) L390-L397
19. Kapoun A.M., Gaspar N.J., Wang Y., Damm D., Liu Y.W., O'Young G., Quon D., Lam A., Munson K., Tran T.T., Ma J.Y., Murphy A., Dugar S., Chakravarty S., Protter A.A., Wen F.Q., Liu X., Rennard S.I., and Higgins L.S. Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but Not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression. Mol. Pharmacol. 70 (2006) 518-531
20. Klotz L.O., Pellieux C., Briviba K., Pierlot C., Aubry J.M., and Sies H. Mitogen-activated protein kinase (p38-, JNK-, ERK-) activation pattern induced by extracellular and intracellular singlet oxygen and UVA. Eur. J. Biochem. 260 (1999) 917-922
21. Kojima M., Morisaki T., Izuhara K., Uchiyama A., Matsunari Y., Katano M., and Tanaka M. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation. Oncogene 19 (2000) 1225-1231
22. Koto H., Salmon M., Haddad e., Huang T.J., Zagorski J., and Chung K.F. Role of cytokine-induced neutrophil chemoattractant (CINC) in ozone-induced airway inflammation and hyperresponsiveness. Am. J. Respir. Crit. Care Med. 156 (1997) 234-239
23. Kristof A.S., Marks-Konczalik J., and Moss J. Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. J. Biol. Chem. 276 (2001) 8445-8452
24. Kumar S., Boehm J., and Lee J.C. P38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nature Rev. Drug Discov. 2 (2003) 717-726
25. Lama V., Moore B.B., Christensen P., Toews G.B., and Peters-Golden M. Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am. J. Respir. Cell Mol. Biol. 27 (2002) 752-758
26. Lander H.M., Jacovina A.T., Davis R.J., and Tauras J.M. Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem. 271 (1996) 19705-19709
27. Lee H., Kim H., Moon C., Chong Y., and Kang J. Inhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injury. Respir. Res. 5 (2004) 23
28. Lim M.Y., Wang H., Kapoun A.M., O'Connell M., O'Young G., Brauer H.A., Luedtke G.R., Chakravarty S., Dugar S., Schreiner G.S., Protter A.A., and Higgins L.S. p38 inhibition attenuates the pro-inflammatory response to C-reactive protein by human peripheral blood mononuclear cells. J. Mol. Cell. Cardiol. 37 (2004) 1111-1114
29. Machino T., Hashimoto S., Maruoka S., Gon Y., Hayashi S., Mizumura K., Nishitoh H., Ichijo H., and Horie T. Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates hydrogen peroxide-induced apoptosis in human pulmonary vascular endothelial cells. Crit. Care Med. 31 (2003) 2776-2781
30. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell Physiol. 192 (2002) 1-15
31. Matsukawa J., Matsuzawa A., Takeda K., and Ichijo H. The ASK1-MAP kinase cascades in mammalian stress response. J. Biochem. 136 (2004) 261-265
32. Medicherla S., Ma J.Y., Mangadu R., Jiang Y., Zhao J.J., Almirez R., Kerr I., Stebbins E.G., O'Young G., Kapoun A.M., Luedtke G., Chakravarty S., Dugar S., Genant H.K., and Protter A.A. A selective p38{alpha} mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis. J. Pharmacol. Exp. Ther. 318 (2006) 132-141
33. Medina-Ramon M., Zanobetti A., and Schwartz J. The effect of ozone and PM10 on Hospital admissions for pneumonia and chronic obstructive pulmonary disease: a national multicity study. Am. J. Epidemiol. 163 (2006) 579-588
34. Nabeyrat E., Jones G.E., Fenwick P.S., Barnes P.J., and Donnelly L.E. Mitogen-activated protein kinases mediate peroxynitrite-induced cell death in human bronchial epithelial cells. A.J.P. - Lung Cell. Mol. Physiol. 284 (2003) L1112-L1120
35. Nath P., Eynott P., Leung S.Y., Adcock I.M., Bennett B.L., and Chung K.F. Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125. Eur. J. Pharmacol. 506 (2005) 273-283
36. Nath P., Leung S.Y., Williams A., Noble A., Chakravarty S.D., Luedtke G.R., Medicherla S., Higgins L.S., Protter A., and Chung K.F. Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness. Eur. J. Pharmacol. 544 (2006) 160-167
37. Park J.W., Taube C., Swasey C., Kodama T., Joetham A., Balhorn A., Takeda K., Miyahara N., Allen C.B., Dakhama A., Kim S.H., Dinarello C.A., and Gelfand E.W. Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am. J. Respir. Cell. Mol. Biol. 30 (2004) 830-836
38. Peel J.L., Tolbert P.E., Klein M., Metzger K.B., Flanders W.D., Todd K., Mulholland J.A., Ryan P.B., and Frumkin H. Ambient air pollution and respiratory emergency department visits. [Article]. Epidemiology 16 (2005) 164-174
39. Pendino K.J., Shuler R.L., Laskin J.D., and Laskin D.L. Enhanced production of interleukin-1, tumor necrosis factor-alpha, and fibronectin by rat lung phagocytes following inhalation of a pulmonary irritant. Am. J. Respir. Cell. Mol. Biol. 11 (1994) 279-286
40. Rahman I., and Adcock I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J. 28 (2006) 219-242
41. Schieke S.M., Briviba K., Klotz L.O., and Sies H. Activation pattern of mitogen-activated protein kinases elicited by peroxynitrite: attenuation by selenite supplementation. F.E.B.S. Lett. 448 (1999) 301-303
42. Seltzer J., Bigby B.G., Stulbarg M., Holtzman M.J., Nadel J.A., Ueki I.F., Leikauf G.D., Goetzl E.J., and Boushey H.A. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J. Appl. Physiol. 60 (1986) 1321-1326
43. Sen C.K. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem. Pharmacol. 55 (1998) 1747-1758
44. Shore S.A., Johnston R.A., Schwartzman I.N., Chism D., and Krishnamurthy G.G. Ozone-induced airway hyperresponsiveness is reduced in immature mice. J. Appl. Physiol. 92 (2002) 1019-1028
45. 2-induced proliferation of primary alveolar epithelial cells is mediated by MAP kinases. Antioxid. Redox Signal. 7 (2005) 6-13
46. Stenfors N., Pourazar J., Blomberg A., Krishna M.T., Mudway I., Helleday R., Kelly F.J., Frew A.J., and Sandstrom T. Effect of ozone on bronchial mucosal inflammation in asthmatic and healthy subjects. Respir. Med. 96 (2002) 352-358
47. Sweitzer S.M., Medicherla S., Almirez R., Dugar S., Chakravarty S., Shumilla J.A., Yeomans D.C., and Protter A.A. Antinociceptive action of a p38[alpha] MAPK inhibitor, SD-282, in a diabetic neuropathy model. Pain 109 (2004) 409-419
48. Thannickal V.J., and Fanburg B.L. Reactive oxygen species in cell signaling. A.J.P. - Lung Cell Mol. Physiol. 279 (2000) L1005-L1028
49. Vagaggini B., Carnevali S., Macchioni P., Taccola M., Fornai E., Bacci E., Bartoli M.L., Cianchetti S., Dente F.L., Di Franco A., Giannini D., and Paggiaro P.L. Airway inflammatory response to ozone in subjects with different asthma severity. Eur. Respir. J. 13 (1999) 274-280
50. Valacchi G., Pagnin E., Corbacho A.M., Olano E., Davis P.A., Packer L., and Cross C.E. In vivo ozone exposure induces antioxidant/stress-related responses in murine lung and skin. Free Radic. Biol. Med. 36 (2004) 673-681
51. Valacchi G., Pagnin E., Okamoto T., Corbacho A.M., Olano E., Davis P.A., Vliet A.v.d., Packer L., and Cross C.E. Induction of stress proteins and MMP-9 by 0.8 ppm of ozone in murine skin. Biochem. Biophys. Res. Comm. 305 (2003) 741-746
52. Zarubin T., and Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15 (2005) 11-18
53. Zhang L.Y., Levitt R.C., and Kleeberger S.R. Differential susceptibility to ozone-induced airways hyperreactivity in inbred strains of mice. Exp. Lung Res. 21 (1995) 503-518